Financial Results : Almujtama Alraida H1 2025 profit soars 115% to SAR 4.3M

Almujtama Alraida H1 2025 profit soars 115% to SAR 4.3M

04/08/2025 Argaam Exclusive

View other reports

Almujtama Alraida Medical Co. posted a 115% surge in its net income for the first half of 2025 to SAR 4.3 million, compared to SAR 2 million in the corresponding period of 2024.



Current Half Annual Comparison (M)

Compared With The
Item H1 2024 H1 2025 Change‬
Revenues 209.40 235.02 12.2 %
Gross Income 68.86 75.30 9.4 %
Operating Income 3.62 6.20 71.4 %
Net Income 1.98 4.26 115.2 %
Average Shares 9.50 9.50 -
Earnings Per Share before unusual items (Riyal) 0.21 0.45 115.2 %
EPS (Riyal) 0.21 0.45 115.2 %

The profit growth during the current period was attributed to higher revenues driven by the expansion of the company’s pharmacy network and its commitment to providing competitive value to customers.

 

In addition, the company witnessed an increase in gross profit by SAR 6.4 million, reaching SAR 75.3 million in H1 2025, on the company’s ongoing investment strategy aimed at supporting sales growth.

 

On the other hand, the company reported a rise of SAR 3.6 million in operating expenses (OpEx), as it supported its investments, including new openings across the Kingdom.

 

There was also an increase of SAR 665,000 compared to the same period last year, primarily due to interest expense related to lease obligations, to support sales growth.

 

Compared to H2 2024, net profit fell 28.3% from SAR 5.95 million.

 

Additional Info:

 

Total shareholders’ equity, no minority interest, decreased to SAR 142.4 million as of June 30, 2025, from SAR 131.76 million a year earlier.

View more financial results

 

Kindly, you can view the full report by subscribing to the

The report contains the details of the financial statements, The most important financial indicators, Historical information, Charts, and Forecasts of experts.

Contact Us (+966)-92000-7759

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
loader Train
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.